| Financial Year |
March 31 2023 |
| Monetary Funds |
1,000,503,224.05 |
| Held-for-trading Financial Assets |
6,174,671.58 |
| Notes Receivable |
-- |
| Accounts Receivable |
262,329,178.51 |
| Advances to Suppliers |
78,566,740.04 |
| Other Receivables |
215,524,624.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
38,250,000.00 |
| Inventories |
295,173,818.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
66,612,271.58 |
| Total Current Assets |
1,924,884,529.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
437,561,440.96 |
| Investment Properties |
-- |
| Fixed Assetes |
452,228,596.98 |
| Under-construction Projects |
22,078,194.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,660,861.62 |
| R&D expenses |
-- |
| Goodwill |
75,650,750.09 |
| Long-Term Deferred and Prepaid Expenses |
37,369,242.42 |
| Deferred Income Tax Assets |
18,310,120.81 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,151,284,883.35 |
| Total Assets |
3,076,169,412.73 |
| Short-Term Loans |
60,003,583.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
117,766,146.00 |
| Accounts Received In Advance |
636,536.15 |
| Employee Compensation Payable |
16,861,955.97 |
| Taxes Payable |
20,015,050.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
60,472,001.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,288,624.92 |
| Other Current Liabilities |
163,703.89 |
| Sub-Total of Current Liabilities |
279,059,281.15 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,830,151.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,765,054.43 |
| Total Liabilities |
301,824,335.58 |
| Paid-In Capital(Or Share Stock) |
238,571,459.00 |
| Capital Surplus |
1,457,406,709.30 |
| Surplus Reserve |
92,980,116.09 |
| LESS:Treasury Stock |
55,916,711.25 |
| Undistributed Profits |
1,037,410,799.00 |
| Minority Stockholder's Interest |
827,426.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,773,517,650.57 |
| Owner's Equity（Stockholder's Equity） |
2,774,345,077.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,076,169,412.73 |
